Last updated on February 2018

A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature

Brief description of study

This study aims to explore the optimal dose of pegylated recombinant human growth hormone (PEG-rhGH) injection to treat children with idiopathic short stature (ISS), evaluate its safety and efficacy, and provide scientific and reliable evidence for the medication dosage in Phase III clinical study.

Clinical Study Identifier: NCT03221088

Contact Investigators or Research Sites near you

Start Over

Hongwei Du, MD

The First Hospital of Jilin University
Changchun, China
  Connect »